Heart failure

Heart diseases associated with Diabetes

Inherited Cardiomyopathies;

Family screening

Hypertrophic cardiomyopathy

Dilated cardiomyopathy

Valve pathologies

Heart diseases of elderly people with co-morbidities

Cardiac computed tomography (CTCA)

Perfusion cardiac magnetic resonance (CMR) and stress echo (DSE)

Hypertension

High cardiovascular risk

PhD in Cardiovascular Science University of Edinburgh 2008

MRCP RCP London 2009

MSc in Research University of Edinburgh 2008

MD Medical University of Warsaw/Freie Universitaet in Berlin 2003

Fellow of the European Society of Cardiology

Royal College of Physicians

Society of Cardiovascular Magnetic Resonance

Society of Cardiovascular Computed Tomography

British Society of Echocardiography

British Society of Magnetic Resonance

European Society of Cardiovascular Imaging

Latest PubMed list of publications

Publications:

1. Rahimi K, Bidel Z, Nazarzadeh M, Coplan E, Canoy D, Wamil M, Majert J, McManus R; Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis, Lancet 26 Aug 2021 S0140-6736(21)01921-8.

2. Nazarzadeh M, Bidel Z, Coplan E, Canoy D, Wamil M, Majert J, Byrne K, Sundstrom J, Teo K, Davis B, Chalmers J, Pepine C, Dehghan A, Bennett D, Smith D, Rahimi K; Blood pressure lowering and risk of new-onset type 2 diabetes: evidence from genetic analysis and individual participant data meta-analysis of randomised controlled trials, Lancet 2021 Nov 13;398(10313):1803-1810

3. Wamil M, Coleman R, Adler IA, McMurray J, Holman RR; Increased Risk of Incident Heart Failure and All-cause Mortality in People with Insulin Resistance in the United Kingdom Prospective Diabetes Study: UKPDS; Diabetes Care 2021 Aug;44(8):1877-1884

4. Dennis A, Wamil M, Alberts J, Oben J, Cuthbertson DJ, Wootton D, Crooks M, Gabbay M, Brady M, Hishmeh L, Attree E, Heightman M, Banerjee R, Banerjee A; COVERSCAN study investigators; Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study BMJ Open 2021 Mar 30;11(3): e 048391

5. Wamil M, McMurray JJ, Scott CAB, Coleman RL, Sun Y, Standl E, Rydén L, Holman RR Incidence, predictors, and importance of heart failure events in patients with impaired glucose tolerance in the Acarbose Cardiovascular Evaluation (ACE) trial, Diabetes Research and Clinical Practice 2020 Dec 170:108488

6. Wamil M, Borlotti A, Briosa e Gala A, Bracco A, Liu D, Piechnik S, Ferreira V, Alkalil M, DeMaria G, Fahrni G, Dawkins S, Wolfrum M, Banning A, Kharbanda R, Neubauer S, Choudhury R, Channon K, Dall’Armellina E Combined T1-mapping and tissue tracking analysis improves assessment of adverse LV remodeling following acute STEMI- an Oxford Acute Myocardial Infarction (OxAMI) study International Journal of Cardiovascular Imaging 2019 Jul, 5(7):1297-1308

7. De Ferrari G, Stevens S, Ambrosio G, Leonardi S, McGuire DK, Armstrong PD, Green JB, Wamil M, Holman RR, Peterson ED; on behalf of the TECOS Study Group; Low-Density Lipoprotein Cholesterol Treatment Patterns and Associated Outcomes in Patients with Type 2 Diabetes and Established Cardiovascular Disease: Insights from TECOS, American Heart Journal 2020 Feb;220:82-88

8. Wamil M, Bull S and Newton J. The modern role of transoesophageal echocardiography in the management of valvular pathologies. Echo Research and Practice Jan 17

9. Wamil M, Newton J and Bull S. TOE-what a general cardiologist needs to know? Heart 2017 Apr;103(8):629-640

10. Bajgent C, Laundray M et al. Collins R and SHARP Investigators. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial Lancet 2011 Jun 9; 377(9784): 2181–2192

11. Digby, J, Martinez F, Jefferson A, Wamil M, Ruparelia N, Greaves D and Choudhury R. Anti-inflammatory effects of nicotinic acid in human monocytes are mediated by GPR109A dependent mechanisms. Atherosclerosis, Thrombosis and Vascular Biology 2012 Mar;32(3):669-76.

12. Wamil M, Battle JH, Turban S, Kipari T, Peixoto RS, Fernbach D, Ramage L, Chapman KE, Hughes J, Dunbar D, Seckl JR and Morton NM. Depot-specific insulin-sensitizion and reduced inflammation drives the protective fat distribution of 11β-HSD1-/- mice. Diabetes 2011, Apr;60(4):1158-67.

13. Wamil M, Andrew R, Chapman K, Street J, Morton NM, Seckl JR. 7-oxysterols modulate glucocorticoid activity in adipocytes. Endocrinology. 2008, Dec;149(12):5909-18

14. Wamil M., Seckl JR. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target. Drug Discovery Today. 2007, Jul; 12(13-14):504-520.

15. Morton NM, Densmore V, Wamil M, Ramage L, Nichol K, Bünger L, Seckl JR and Kenyon CJ. A polygenic model of the metabolic syndrome with reduced circulating and intra-adipose glucocorticoid action Diabetes. 2005, Dec; 54(12):3371-8.

16. Snarski E, Kedzierska M, Wamil M, Prejbisz A, Pedzisz P, Wiktor-Jedrzejczak W. (2002, February 1). Time till diagnosis in blood neoplasia - an index of the efficiency of health care system? Acta Hematologica 33, 257-262.

17. Szopa M, Wamil M. (2007, May 20). 11beta-hydroxysteroid dehydrogenase type 1 inhibitor: a novel therapeutic target in the metabolic syndrome. Diabetologia Praktyczna 8, 77-83.

18. Maurin JK, Lasek W, Gorska A, Switaj T, Wamil M, Mlynarczuk I, Kazimierczuk Z. Synthesis, structure and tumour necrosis factor-alpha production-enhancing properties of novel adamantylamino heterocyclic derivatives. Anticancer Drug Design 2001, Apr; 16(2-3):73-80.